Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.69 USD | +0.52% | +6.11% | +27.92% |
Business Summary
Number of employees: 305
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life-changing Medicines
100.0
%
| 0 | nan % | 5 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 5 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Saqib Islam
CEO | Chief Executive Officer | 54 | 01/17/01 |
Daniel Lynch
CHM | Chairman | 65 | 01/16/01 |
Frank Perier
DFI | Director of Finance/CFO | 64 | 01/19/01 |
Tai-An Lin
CTO | Chief Tech/Sci/R&D Officer | 61 | 11/23/11 |
James Cassidy
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/21/01 |
Badreddin Edris
COO | Chief Operating Officer | 37 | 01/18/01 |
Kim Diamond
IRC | Investor Relations Contact | - | 01/18/01 |
Bhavesh Ashar
PRN | Corporate Officer/Principal | 58 | 22/21/22 |
Daniel Pichl
HRO | Human Resources Officer | 41 | 01/20/01 |
Michael Nofi
AUD | Comptroller/Controller/Auditor | 53 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Fuhrman
BRD | Director/Board Member | 67 | 01/19/01 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 01/17/01 |
Carlos Alban
BRD | Director/Board Member | 61 | 14/22/14 |
Daniel Lynch
CHM | Chairman | 65 | 01/16/01 |
Saqib Islam
CEO | Chief Executive Officer | 54 | 01/17/01 |
Julie Hambleton
BRD | Director/Board Member | 66 | 20/20/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,193,558 | 70,439,695 ( 94.94 %) | 133,662 ( 0.1802 %) | 94.94 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.92% | 3.44B | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.32% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- SWTX Stock
- Company SpringWorks Therapeutics, Inc.